Through this agreement, Recursion will integrate HealthVerity de-identified data for over 340M covered lives within the US into its advanced data science and machine learning platforms ...

REC-163964 is the first internally-discovered New Chemical Entity (NCE) development candidate identified by the Recursion Operating System and advanced to IND-enabling studies. This lead ...

KUALA LUMPUR, Nov 21 (Bernama) -- Recursion has completed its merger with Exscientia ... includes more than 10 clinical and preclinical programmes, approximately 10 advanced discovery programmes in ...